Shelton Capital Management Gilead Sciences, Inc. Transaction History

Shelton Capital Management

$3.62 Billion
Q2 2024

A detailed history of Shelton Capital Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Shelton Capital Management holds 159,069 shares of GILD stock, worth $13.3 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

159,069

Previous 158,886 0.12%

Holding current value

$13.3 Million

Previous $11.6 Million 6.23%

% of portfolio

0.3%

Previous 0.34%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $11,556 - $13,337	183 Added 0.12%	159,069 $10.9 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $3.65 Million - $4.45 Million	-50,955 Reduced 24.28%	158,886 $11.6 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $7.41 Million - $8.41 Million	-101,172 Reduced 32.53%	209,841 $17 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $3.39 Million - $3.69 Million	45,787 Added 17.26%	311,013 $23.3 Million
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $4.51 Million - $5.15 Million	59,389 Added 28.85%	265,226 $20.4 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $14.2 Million - $16.1 Million	183,237 Added 810.78%	205,837 $17.1 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $6.4 Million - $9.19 Million	-102,683 Reduced 81.96%	22,600 $1.94 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $6.95 Million - $7.94 Million	-116,775 Reduced 48.24%	125,283 $7.73 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $311,457 - $350,793	-5,396 Reduced 2.18%	242,058 $15 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $630,401 - $789,960	10,884 Added 4.6%	247,454 $14.7 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $3.41 Million - $3.87 Million	52,511 Added 28.53%	236,570 $17.2 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $281,522 - $303,731	-4,159 Reduced 2.21%	184,059 $12.9 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $13.1 Million - $14.3 Million	-206,814 Reduced 52.35%	188,218 $13 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $10 Million - $11.4 Million	166,793 Added 73.08%	395,032 $25.5 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $1.89 Million - $2.16 Million	33,425 Added 17.16%	228,239 $13.3 Million
Q3 2020 Nov 09, 2020	BUY	$62.1 - $78.08 $1.15 Million - $1.44 Million	18,494 Added 10.49%	194,814 $12.3 Million
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $2.41 Million - $2.79 Million	33,260 Added 23.25%	176,320 $13.6 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $4.57 Million - $5.85 Million	-72,910 Reduced 33.76%	143,060 $10.7 Million
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $3.99 Million - $4.39 Million	64,812 Added 42.88%	215,970 $14 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $797,690 - $880,509	-12,761 Reduced 7.78%	151,158 $9.58 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $9.48 Million - $10.6 Million	153,263 Added 1438.28%	163,919 $11.1 Million
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $9.58 Million - $10.7 Million	-153,228 Reduced 93.5%	10,656 $164 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $1.47 Million - $1.63 Million	-20,600 Reduced 11.17%	163,884 $12.7 Million
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $279,567 - $326,105	4,309 Added 2.39%	184,484 $13.1 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $446,145 - $543,900	6,125 Added 3.52%	180,175 $13.6 Million
Q4 2017 Feb 06, 2018	SELL	$71.15 - $83.52 $381,435 - $447,750	-5,361 Reduced 2.99%	174,050 $12.5 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $1.7 Million - $2.02 Million	-23,600 Reduced 11.62%	179,411 $14.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	46,887 Added 30.03%	203,011 $14.4 Million
Q1 2017 Nov 28, 2017	BUY	N/A	18,155 Added 13.16%	156,124 $10.6 Million
Q4 2016 Nov 29, 2017	SELL	N/A	-8,700 Reduced 5.93%	137,969 $9.88 Million
Q3 2016 Dec 06, 2017	BUY	N/A	8,700 Added 6.31%	146,669 $11.6 Million
Q3 2016 Dec 04, 2017	BUY	N/A	137,969	137,969 $9.88 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.

Account

Shelton Capital Management Gilead Sciences, Inc. Transaction History